The eight main blood types are A+, A-, B+, B-, O+, O-, AB+, and AB-. The most common blood type in the United States is O-positive, with around 38 percent of the population having this type of blood. However, blood type O-positive is more common in Latino-Americans than other ethnicities, with around 53 percent of Latino-Americans with this blood type, compared to 47 percent of African Americans and 37 percent of Caucasians. Blood donation The American Red Cross estimates that every two seconds someone in the United States needs blood or platelets, highlighting the importance of blood donation. It was estimated that in 2021, around 6.5 million people in the U.S. donated blood, with around 1.7 million of these people donating for the first time. Those with blood type O-negative are universal blood donors, meaning their blood can be transfused for any blood type. Therefore, this blood type is the most requested by hospitals. However, only about seven percent of the U.S. population has this blood type. Blood transfusion Blood transfusion is a routine procedure that involves adding donated blood to a patient’s body. There are many reasons why a patient may need a blood transfusion, including surgery, cancer treatment, severe injury, or chronic illness. In 2021, there were around 10.76 million blood transfusions in the United States. Most blood transfusions in the United States occur in an inpatient medicine setting, while critical care accounts for the second highest number of transfusions.

The most common blood type among the population in the United States is O-positive. Around 53 percent of the Latino-American population in the U.S. has blood type O-positive, while only around 37 percent of the Caucasian population has this blood type. The second most common blood type in the United States is A-positive. Around 33 percent of the Caucasian population in the United States has A-positive blood type. Blood type O-negative Those with blood type O-negative are universal donors as this type of blood can be used in transfusions for any blood type. O-negative blood type is most common in the U.S. among Caucasian adults. Around eight percent of the Caucasian population has type O-negative blood, while only around one percent of the Asian population has this blood type. Only around seven percent of all adults in the United States have O-negative blood type. Blood Donations The American Red Cross estimates that someone in the United States needs blood every two seconds. However, only around three percent of age-eligible people donate blood yearly. The percentage of adults who donated blood in the United States has not fluctuated much for the past two decades. In 2021, around 15 percent of U.S. adults donated blood, the same share reported in the year 2003.

According to Cognitive Market Research, the global blood group typing market size is USD XX million in 2023 and will expand at a compound annual growth rate (CAGR) of 8.8% from 2024 to 2031.

The global blood group typing market will expand significantly by 8.8% CAGR between 2024 to 2031.
North America held the major market of more than XX% of the global revenue with a market size of USD XX million in 2023 and will grow at a compound annual growth rate (CAGR) of XX% from 2024 to 2031.
Europe accounted for a share of over XX% of the global market size of USD XX million.
Asia Pacific held a market of around XX% of the global revenue with a market size of USD XX million in 2023 and will grow at a compound annual growth rate (CAGR) of XX% from 2024 to 2031.
Latin America's market will have more than XX% of the global revenue with a market size of USD XX million in 2023 and will grow at a compound annual growth rate (CAGR) of XX% from 2024 to 2031.
Middle East and Africa held the major market of around XX% of the global revenue with a market size of USD XX million in 2023 and will grow at a compound annual growth rate (CAGR) of XX% from 2024 to 2031.
The blood group typing industry is set to rise due to increased blood group ownership rates, rising awareness regarding blood group health, accelerated R&D in the blood group typing industry, and the rise of E-commerce. Increasing online retail channels further bolster demand, while cultural significance and investment appeal contribute to its enduring popularity.
The blood group typing market is driven by rising awareness regarding blood group health, accelerated R&D in the blood group typing industry, and the rise of E-commerce.
Antibody Screenings are anticipated to form the majority of blood group owners in the years to come.

Current Scenario of the Blood Group Typing Market

Key Drivers of the Blood Group Typing Market

The growing incidence of chronic illnesses and the increase in surgical operations necessitates the need for blood donations

The demand for blood has grown as chronic diseases and the surgical procedures necessary to treat them have become more common. Blood transfusions are typically necessary for patients with chronic illnesses to manage their symptoms, and large volumes of blood are required for surgical procedures, particularly major surgeries, to ensure safe and effective results. As a result, the need for blood has steadily increased within the healthcare system, which has led to a rise in blood donation rates. The market is anticipated to benefit from this. To treat patients with chronic illnesses and those having difficult surgical operations, the American National Red Cross (2023) estimates that every day, over 29,000 units of red blood cells are required in US hospitals and emergency rooms. For instance, according to the National Center for Biotechnology Information, the number of people 50 years of age and older who have at least one chronic illness is predicted to rise from 71.522 million in 2020 to 142.66 million in 2050, a 99.5% increase.

Source- https://pubmed.ncbi.nlm.nih.gov/36711415/#:~:text=Of%20the%20population%2050%20years,to%2014.968%20million%20in%202050.

Blood group typing is a necessary test that establishes the Rh factor and the level of blood compatibility between the donor and the recipient prior to blood transfusions. Thus, the need for blood donations is a result of the rising prevalence of chronic illnesses and the rise in surgical procedures.

Blood Donation rates have necessitated the need for Blood Group Typing

Global blood donation rates have significantly increased over time. The need for transfusion procedures such as blood type detection and cross-matching has surged due to a rise in voluntary blood donations. The National Health Service Blood and Transplant (NHSBT) receives over 1.5 million voluntary blood donations annually, which are processed by the government before being given to hospitals and patients in need, according to an article published by the European Blood Alliance (EBA) (2019–2022).

Source- https://www.nhsbt.nhs.uk/who-we-are/a-history-of-donation-transfusion-and-transplantation/

NHSBT supplies hospitals in England with a secure and dependable supply of blood components, diagnostic services, and stem cell treatments. To do this, it depends on 1...

This statistic illustrates the distribution of blood groups in the French population, according to the Rhesus system. It shows that less than *** percent of French people had the blood group AB negative.

Fresh Frozen Plasma Market Outlook

The global fresh frozen plasma market size was valued at approximately USD 2.8 billion in 2023 and is projected to reach nearly USD 4.2 billion by 2032, growing at a compound annual growth rate (CAGR) of 4.6% from 2024 to 2032. One of the primary growth factors driving this market is the increasing prevalence of chronic diseases and the rising number of surgical procedures worldwide.

A significant growth factor for the fresh frozen plasma market is the increasing incidence of trauma and surgical procedures. With a growing global population and higher rates of accidents and injuries, the need for blood and blood components, including fresh frozen plasma, has surged. Moreover, advancements in medical technology and healthcare infrastructure have made complex surgical procedures more common, further boosting the demand for plasma. The continuous development and improvement of blood transfusion services in developing countries also contribute to market growth.

Another critical factor propelling the market is the rising prevalence of liver diseases and coagulation disorders. Conditions such as liver cirrhosis, liver failure, and various types of hemophilia necessitate the administration of fresh frozen plasma to manage patient conditions effectively. The increase in these diseases can be attributed to lifestyle changes, increased alcohol consumption, and better diagnostic capabilities. As healthcare providers and patients become more aware of the benefits of plasma therapy, the market is expected to experience sustained growth.

Additionally, the growing geriatric population worldwide is a vital driver of market expansion. Older adults are more susceptible to chronic conditions and often require surgical interventions and blood transfusions. With an aging global population, there is a corresponding rise in the need for medical treatments involving fresh frozen plasma. The increasing focus on improving healthcare services for the elderly, particularly in developed nations, ensures a steady demand for plasma products.

From a regional perspective, North America and Europe currently dominate the fresh frozen plasma market, primarily due to well-established healthcare infrastructure and high awareness levels. However, the Asia-Pacific region is anticipated to witness the highest growth rate during the forecast period. Factors such as increasing healthcare expenditure, improving medical facilities, and rising awareness about plasma donations and transfusions are driving market growth in this region. Countries like China and India are expected to be major contributors to the market's expansion.

Product Type Analysis

The fresh frozen plasma market can be segmented into single donor plasma and pooled plasma. Single donor plasma is sourced from a single individual, ensuring consistency and reducing the risk of transfusion-transmitted infections. This segment is gaining popularity due to its safety profile and effectiveness in treating various medical conditions. Technological advancements in blood collection and processing have further enhanced the quality and safety of single donor plasma, making it a preferred choice for healthcare providers.

Pooled plasma, on the other hand, is derived from multiple donors and mixed together. This type of plasma is often used in large-scale medical treatments and is essential in scenarios where the demand for plasma is high. Pooled plasma is particularly useful in treating coagulation disorders and in situations where a quick supply of plasma is necessary. Despite the increased risk of transfusion-transmitted infections compared to single donor plasma, pooled plasma remains a vital component of the healthcare system.

The rising incidence of trauma and surgical procedures is a significant driver for both single donor and pooled plasma segments. With an increasing number of complex surgeries being performed worldwide, the demand for high-quality plasma products is on the rise. Both types of plasma are crucial in managing blood loss and ensuring patient stability during and after surgical interventions.

Furthermore, the growing prevalence of liver diseases and coagulation disorders has led to a higher demand for plasma products. Single donor plasma is often preferred in these cases due to its consistent quality and lower risk of complications. However, pooled plasma also plays a critical role, particularly in emergency settings where large volumes of plasma are required quickly.

In t